A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 3 837,86 Kč, with a 24-hour trading volume of 21,67M Kč. The asset's market cap is 5,95T Kč, after moving 1.76% in the last day.
Tokenized AstraZeneca PLC is trading at 2 155,92 Kč, with a tokenized market cap of 1,22B Kč and a 24-hour trading volume of 16M Kč. The tokenized asset has moved 5.65% in the past 24 hours.